Celldex Stock Surges As It Touts Early-Stage Skin Disease Study Win For CDX-0159
Celldex Therapeutics Inc (NASDAQ:CLDX) got a boost Friday with a data readout from Phase 1b trial of CDX-0159 in patients with…
WHO Recommends IL-6 Drugs From Sanofi, Roche For Critically-Ill COVID-19 Patients
The World Health Organization (WHO) has endorsed Interleukin-6 (IL-6) receptor antagonists combined with corticosteroids to treat severe COVID-19 cases. Patients…
Novartis Claims It Overpaid Genentech $210M In Patent Licensing Pact
Novartis AG (NYSE: NVS) said it dutifully paid millions to Genentech as part of a patent licensing deal dated back to 2005.
Exelixis Shares Drop On Mixed Results For Cabometyx Combo In Early Liver Cancer
Exelixis Inc (NASDAQ:EXEL) and Ipsen (OTC:IPSEY) have announced mixed interim results from the COSMIC-312 Phase 3 trial evaluating cabozantinib (Cabometyx) in combination with Roche…
FDA Gives Emergency Use Nod For Roche’s Arthritis Drug Against Severe COVID-19
The FDA has approved Roche Holding AG’s (OTC:RHHBY) arthritis drug Actemra (tocilizumab) for emergency use to treat adults and pediatric patients…
Roche’s Alzheimer’s Antibody Reduces Associated Biomarkers In Subset Of AD Patients, Study Shows
Experimental anti-amyloid antibodies from Eli Lilly & Co (NYSE:LLY) and Roche Holding AG’s (OTC:RHHBY) failed to improve symptoms of Alzheimer’s disease (AD)…
Roche’s New COVID-19 Point Of Care Test Scores FDA Emergency Use Nod
The FDA has granted Emergency Use Authorization (EUA) to Roche Holding AG’s (OTC:RHHBY) Cobas SARS-CoV-2 Nucleic acid test for use on the…
Amneal’s Avastin-Referred Biosimilar Under FDA Review For Colorectal Cancer
The FDA has accepted for review Amneal Pharmaceuticals Inc’s (NYSE:AMRX) marketing application seeking approval for Bevacizumab, under Section 351(k) pathway of…
Synlogic, Roche Ink Research Pact For Inflammatory Bowel Disease Therapy
Synlogic Inc (NASDAQ:SYBX) has entered into a research collaboration agreement with Roche Holding AG (OTC:RHHBY) for the discovery of Synthetic Biotic medicine…
Atea Pharma Secures AT-527-Related Milestone Payment Of $50M From Roche
Atea Pharmaceuticals Inc (NASDAQ:AVIR) has achieved a development milestone associated with AT-527 and expects to receive a related payment under its…